ADC Therapeutics SA (ADCT) — Financial Flexibility Index
ADC Therapeutics SA (ADCT) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-29.68 Million (operating CF $-29.71 Million minus capex $32.00K) represents 0% of total liabilities ($507.87 Million). Also explore net asset growth rate of ADC Therapeutics SA to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ADC Therapeutics SA Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for ADC Therapeutics SA across 9 annual periods. Check ADC Therapeutics SA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ADC Therapeutics SA (2017–2025)
Year-by-year free cash flow to debt coverage for ADC Therapeutics SA. For the full company profile including market capitalisation, see ADC Therapeutics SA (ADCT) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-140.91 Million | $-141.17 Million | $508.98 Million | ▼ -18.1% |
| 2024 | -0.23x | $-122.97 Million | $-123.83 Million | $524.62 Million | ▼ -2.1% |
| 2023 | -0.23x | $-115.47 Million | $-118.69 Million | $503.03 Million | ▲ +31.4% |
| 2022 | -0.33x | $-137.62 Million | $-138.31 Million | $411.41 Million | ▲ +33.4% |
| 2021 | -0.50x | $-227.00 Million | $-233.38 Million | $451.88 Million | ▲ +46.1% |
| 2020 | -0.93x | $-165.92 Million | $-168.73 Million | $178.19 Million | ▲ +79.3% |
| 2019 | -4.50x | $-119.43 Million | $-121.58 Million | $26.53 Million | ▲ +7.9% |
| 2018 | -4.89x | $-118.89 Million | $-121.36 Million | $24.32 Million | ▼ -55.2% |
| 2017 | -3.15x | $-71.79 Million | $-74.94 Million | $22.78 Million | — |